A role of phosphodiesterase-3B pathway in mediating leptin action on proopiomelanocortin and neurotensin neurons in the hypothalamus

Neuroscience Letters

Volumn 479, Issue 1, 2010, Pages 18-21

  Sahu, Abhiram ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Hypothalamus; Leptin; NT; Phosphodiesterase 3B; POMC

Indexed keywords

CILOSTAMIDE; LEPTIN; MESSENGER RNA; NEUROTENSIN; PHOSPHODIESTERASE 3B; PHOSPHODIESTERASE III; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG; PDE3B PROTEIN, RAT; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE INHIBITOR; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ENERGY BALANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE RESPONSE; HYPOTHALAMUS; INTRACELLULAR SIGNALING; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WEIGHT REDUCTION; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; GENE EXPRESSION; HYPOTHALAMUS; LEPTIN; MALE; MODELS, NEUROLOGICAL; NEURONS; NEUROTENSIN; PHOSPHODIESTERASE INHIBITORS; PRO-OPIOMELANOCORTIN; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; PHOSPHODIESTERASE 3 INHIBITORS;

EID: 77953693953     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.018     Document Type: Article

References (55)

1. Al-Qassab H., Smith M.A., Irvine E.E., Guillermet-Guibert J., Claret M., Choudhury A.I., Selman C., Piipari K., Clements M., Lingard S., Chandarana K., Bell J.D., Barsh G.S., Smith A.J., Batterham R.L., Ashford M.L., Vanhaesebroeck B., Withers D.J. Dominant role of the p110β isoform of PI3K over p110α in energy homeostasis regulation by POMC and AgRP neurons. Cell Metab. 2009, 10:343-354.
2. Balthasar N., Coppari R., McMinn J., Liu S.M., Lee C.E., Tang V., Kenny C.D., McGovern R.A., Chua S.C., Elmquist J.K., Lowell B.B. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron 2004, 42:983-991.
3. Banks A.S., Davis S.M., Bates S.H., Myers M.G. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 2000, 275:14563-14572.
4. Bates S.H., Stearns W.H., Dundon T.A., Schubert M., Tso A.W., Wang Y., Banks A.S., Lavery H.J., Haq A.K., Maratos-Flier E., Neel B.G., Schwartz M.W., Myers M.G. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003, 421:856-859.
5. Baumann H., Morella K.K., White D.W., Dembski M., Bailon P.S., Kim H., Lai C.F., Tartaglia L.A. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:8374-8378.
6. Belgardt B.F., Husch A., Rother E., Ernst M.B., Wunderlich F.T., Hampel B., Klockener T., Alessi D., Kloppenburg P., Bruning J.C. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab. 2008, 7:291-301.
7. Bjorbaek C., Buchholz R.M., Davis S.M., Bates S.H., Pierroz D.D., Gu H., Neel B.G., Myers M.G., Flier J.S. Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 2001, 276:4747-4755.
8. Bjorbaek C., Uotani S., da Silva B., Flier J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem. 1997, 272:32686-32695.
9. Cohen P., Zhao C., Cai X., Montez J.M., Rohani S.C., Feinstein P., Mombaerts P., Friedman J.M. Selective deletion of leptin receptor in neurons leads to obesity. J. Clin. Invest. 2001, 108:1113-1121.
10. Cone R.D. The central melanocortin system and energy homeostasis. Trends Endocrinol. Metab. 1999, 10:211-216.
11. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., Seeley R.J. Hypothalamic mTOR signaling regulates food intake. Science 2006, 312:927-930.
12. Cui H., Cai F., Belsham D.D. Anorexigenic hormones leptin, insulin, and alpha-melanocyte-stimulating hormone directly induce neurotensin (NT) gene expression in novel NT-expressing cell models. J. Neurosci. 2005, 25:9497-9506.
13. El-Haschimi K., Pierroz D.D., Hileman S.M., Bjorbaek C., Flier J.S. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 2000, 105:1827-1832.
14. Elias C.F., Aschkenasi C., Lee C., Kelly J., Ahima R.S., Bjorbaek C., Flier J.S., Saper C.B., Elmquist J.K. Leptin differentially regulates NPY and POMC neurons projecting to the lateral hypothalamic area. Neuron 1999, 23:775-786.
15. Elmquist J.K., Bjorbaek C., Ahima R.S., Flier J.S., Saper C.B. Distributions of leptin receptor mRNA isoforms in the rat brain. J. Comp. Neurol. 1998, 395:535-547.
16. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
17. Gao Q., Wolfgang M.J., Neschen S., Morino K., Horvath T.L., Shulman G.I., Fu X.Y. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4661-4666.
18. Ghilardi N., Skoda R.C. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol. 1997, 11:393-399.
19. Ghilardi N., Ziegler S., Wiestner A., Stoffel R., Heim M.H., Skoda R.C. Defective STAT signaling by the leptin receptor in diabetic mice. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:6231-6235.
20. Halaas J.L., Boozer C., Blair-West J., Fidahusein N., Denton D.A., Friedman J.M. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8878-8883.
21. Hill J.W., Williams K.W., Ye C., Luo J., Balthasar N., Coppari R., Cowley M.A., Cantley L.C., Lowell B.B., Elmquist J.K. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice. J. Clin. Invest. 2008, 118:1796-1805.
22. Hubschle T., Thom E., Watson A., Roth J., Klaus S., Meyerhof W. Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J. Neurosci. 2001, 21:2413-2424.
23. Jakubowski M., Roberts J.L. Multiplex solution hybridization-ribonuclease protection assay for quantification of different ribonucleic acid transcripts from snap-frozen neuroendocrine tissues of individual animals. J. Neuroendocrinol. 1992, 4:79-89.
24. Kahn D., Abrams G.M., Zimmerman E.A., Carraway R., Leeman S.E. Neurotensin neurons in the rat hypothalamus: an immunocytochemical study. Endocrinology 1980, 107:47-54.
25. Kislauskis E., Bullock B., McNeil S., Dobner P.R. The rat gene encoding neurotensin and neuromedin N. Structure, tissue-specific expression, and evolution of exon sequences. J. Biol. Chem. 1988, 263:4963-4968.
26. Kitamura T., Feng Y., Kitamura Y.I., Chua S.C., Xu A.W., Barsh G.S., Rossetti L., Accili D. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat. Med. 2006, 12:534-540.
27. Kowalski T.J., Liu S.M., Leibel R.L., Chua S.C. Transgenic complementation of leptin-receptor deficiency. I. Rescue of the obesity/diabetes phenotype of LEPR-null mice expressing a LEPR-B transgene. Diabetes 2001, 50:425-435.
28. Levin B.E., Dunn-Meynell A.A., Banks W.A. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286:R143-150.
29. Levine A.S., Kneip J., Grace M., Morley J.E. Effect of centrally administered neurotensin on multiple feeding paradigms. Pharmacol. Biochem. Behav. 1983, 18:19-23.
30. Litvin D., Sahu M., Koshinaka K., Sahu A. Evidence showing phosphodiesterase-3B (PDE3B) co-localization in proopiomelanocortin (POMC) and neuropeptide Y (NPY) expressing neurons in the hypothalamus: further insight into leptin signaling. Proceedings of the 89th Annual Meeting of the Endocrine Society 2007, Abst# P4-4.
31. Luttinger D., King R.A., Sheppard D., Strupp J., Nemeroff C.B., Prange A.J. The effect of neurotensin on food consumption in the rat. Eur. J. Pharmacol. 1982, 81:499-503.
32. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferre P., Birnbaum M.J., Stuck B.J., Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 2004, 428:569-574.
33. Munzberg H., Huo L., Nillni E.A., Hollenberg A.N., Bjorbaek C. Role of signal transducer and activator of transcription 3 in regulation of hypothalamic proopiomelanocortin gene expression by leptin. Endocrinology 2003, 144:2121-2131.
34. Niswender K.D., Morton G.J., Stearns W.H., Rhodes C.J., Myers M.G., Schwartz M.W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature 2001, 413:794-795.
35. Ohinata K., Shimano T., Yamauchi R., Sakurada S., Yanai K., Yoshikawa M. The anorectic effect of neurotensin is mediated via a histamine H1 receptor in mice. Peptides 2004, 25:2135-2138.
36. Pal R., Sahu A. Leptin signaling in the hypothalamus during chronic central leptin infusion. Endocrinology 2003, 144:3789-3798.
37. Piper M.L., Unger E.K., Myers M.G., Xu A.W. Specific physiological roles for signal transducer and activator of transcription 3 in leptin receptor-expressing neurons. Mol. Endocrinol. 2008, 22:751-759.
38. Sahu A. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 1998, 139:795-798.
39. Sahu A. Quantification of NPY mRNA by ribonuclease protection assay. Methods Mol. Biol. 2000, 153:219-230.
40. Sahu A. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones. J. Neuroendocrinol. 2002, 14:796-804.
41. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front. Neuroendocrinol. 2003, 24:225-253.
42. Sahu A. Effects of chronic central leptin infusion on proopiomelanocortin and neurotensin gene expression in the rat hypothalamus. Neurosci. Lett. 2008, 440:125-129.
43. Sahu A., Metlakunta A.S. Evidence suggesting phosphatidylinositol 3-Kinase as an upstream regulator of phosphodiesterase 3B mediated leptin signaling in the hypothalamus. Program No. 380. 4. Abstract Viewer/Itinerary Planner 2004, Society for Neuroscience, Washington, DC.
44. Sahu A., Metlakunta A.S. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion. J. Neuroendocrinol. 2005, 17:720-726.
45. Sahu A., Carraway R.E., Wang Y.P. Evidence that neurotensin mediates the central effect of leptin on food intake in rat. Brain Res. 2001, 888:343-347.
46. Sahu A., Crowley W.R., Tatemoto K., Balasubramaniam A., Kalra S.P. Effects of neuropeptide Y, NPY analog (norleucine4-NPY), galanin and neuropeptide K on LH release in ovariectomized (ovx) and ovx estrogen, progesterone-treated rats. Peptides 1987, 8:921-926.
47. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
48. Stanley B.G., Hoebel B.G., Leibowitz S.F. Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats. Peptides 1983, 4:493-500.
49. Tang-Christensen M., Havel P.J., Jacobs R.R., Larsen P.J., Cameron J.L. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J. Clin. Endocrinol. Metab. 1999, 84:711-717.
50. Tartaglia L.A. The leptin receptor. J. Biol. Chem. 1997, 272:6093-6096.
51. Vaisse C., Halaas J.L., Horvath C.M., Darnell J.E., Stoffel M., Friedman J.M. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 1996, 14:95-97.
52. Xu A.W., Ste-Marie L., Kaelin C.B., Barsh G.S. Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding. Endocrinology 2007, 148:72-80.
53. Zhang E.E., Chapeau E., Hagihara K., Feng G.S. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16064-16069.
54. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
55. Zhao A.Z., Huan J.N., Gupta S., Pal R., Sahu A. A phosphatidylinositol 3-kinase phosphodiesterase 3B-cyclic AMP pathway in hypothalamic action of leptin on feeding. Nat. Neurosci. 2002, 5:727-728.